论文部分内容阅读
利福定为异丁基哌嗪力复霉素(简称 R_(76-1))的商品名,是新型力复霉素类抗生素,国内于1976年试制成功。经临床前药理试验及临床试用,结果满意,目前已投放市场。兹对利福定作简单介绍,供参考。一、试管内对结核菌的抑菌作用在试管内,利福定对结核菌有很强的抑制作用,其最低抑菌浓度随培养基不同而异。以标准人型结核菌为试验菌株,在改良苏通半流体培养基上,其最低抑菌浓度为0.05微克/毫升(利福平为0.5微克/毫
Rifaben is isobutylpiperazine force of daunorubicin (referred to as R_ (76-1)) of the trade name, is a new force of doxycycline antibiotics, the domestic trial success in 1976. The pre-clinical pharmacological tests and clinical trials, the results are satisfactory, has been put on the market. We hereby make a brief introduction to Lifestyle for your reference. First, the in vitro test tube antibacterial effect of tuberculosis in vitro test tube, rifamycin on tuberculosis has a strong inhibitory effect, the minimum inhibitory concentration varies with the medium. The standard strain of Mycobacterium tuberculosis as a test strain, modified Sutong semi-fluid medium, the minimum inhibitory concentration of 0.05 micrograms / ml (rifampicin 0.5 micrograms / milliliter